EMCDDA Director at German Bundestag hearing on new psychoactive substances

Director at BundestagEMCDDA Director Alexis Goosdeel is in Berlin today where he is speaking at a public hearing at the German Parliament (Bundestag) on the issue of new psychoactive substances (NPS). The hearing is organised by the Bundestag Health Committee and chaired by Dr Edgar Franke (Member of the German Parliament).

The public hearing is considering two proposals:

Mr Goosdeel is speaking on the policy challenges presented by the NPS phenomenon and the achievements of the EU Early Warning System through which the EMCDDA and Europol  monitor these substances.

Participants at the public hearing include experts from: the Federal Association of Psychotherapists; a health insurance umbrella organisation; associations of therapists; criminal law experts and researchers in the area of drugs and addictions in Germany.

For more, see http://www.bundestag.de/

News by year

Media support

To schedule interviews, obtain informed comment, request written contributions or receive the latest news on the agency, please contact our media relations sector:

Kathy Robertson
Head of sector
Media relations and marketing
Tel: (351) 211 21 02 00/32
Fax: (351) 211 21 03 80